Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled date : 2020 - 12 - 11 save search
Seagen Announces Positive CHMP Opinion for TUKYSA® (tucatinib) for the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer
Published: 2020-12-11 (Crawled : 15:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.34%
H: 2.6%
C: 2.13%
breast cancer cancer positive treatment chmp her2+ her2- her2
Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic® (fedratinib) for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis
Published: 2020-12-11 (Crawled : 15:00) - biospace.com/
BMY | $47.84 -0.87% 0.48% 9.9M
|
Health Technology
|
| O: 0.22%
H: 1.89%
C: 0.65%
positive chmp
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as First-Line Treatment in Adult Patients With Metastatic Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer
Published: 2020-12-11 (Crawled : 15:00) - biospace.com/
MRK | $125.37 0.25% -0.1% 440
|
Health Technology
|
| O: -0.17%
H: 0.69%
C: 0.13%
cancer positive colorectal cancer chmp keytruda
BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Published: 2020-12-11 (Crawled : 15:00) - biospace.com/
PFE A | $25.42 -1.05% 0.16% 40M
|
Health Technology
|
| O: 0.58%
H: 0.24%
C: -2.03%
positive treatment chmp urothelial carcinoma
vTv Therapeutics to Present Additional Positive Clinical Study Results from Phase 2 Simplici-T1 Study of TTP399 as Adjunctive Therapy for Patients with Type 1 Diabetes at EASD Virtual Meeting
Published: 2020-09-16 (Crawled : 14:47) - ir.vtvtherapeutics.com
VTVT | $24.15 0.08% -0.21% 16K
|
Health Technology
|
| O: 4.1%
H: 4.43%
C: 0.49%
diabetes therapy positive results phase 2 ttp399
vTv Therapeutics Presents Additional Positive Clinical Study Results Supporting the Safety and Efficacy of TTP399 as Adjunctive Therapy in Patients with Type 1 Diabetes
Published: 2020-09-23 (Crawled : 14:47) - ir.vtvtherapeutics.com
VTVT | $24.15 0.08% -0.21% 16K
|
Health Technology
|
| O: 12.3%
H: 2.86%
C: -13.81%
diabetes therapy positive results ttp399
SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast
Published: 2020-12-11 (Crawled : 14:01) - globenewswire.com
SLS | $1.41 3.68% 3.2% 560K
|
Health Technology
|
| O: -24.63%
H: 8.19%
C: -37.11%
positive trial phase 2
Xeris Pharmaceuticals Receives Positive CHMP Opinion for Ogluo™, Its Ready-To-Use (RTU) Glucagon for Injection, for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus
Published: 2020-12-11 (Crawled : 10:00) - biospace.com/
XERS | $1.78 -1.11% -0.56% 1.5M
|
Health Technology
|
| O: 6.36%
H: 8.74%
C: 5.06%
diabetes hypoglycaemia positive injection chmp children
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 49.67% 1.4M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
HOLO | $2.24 -5.49% 27.74% 7.7M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VIAO | $0.262 0.77% 16.03% 14M
|
Electronic Technology
DXF | $0.2708 -5.71% 14.48% 190K
|
Finance
GRFX | $0.2159 -10.04% 12.55% 5.9K
|
n/a
BHIL | $0.1722 -3.8% 12.08% 290K
|
Agriculture, Forestry, Fishing ...
MCW 4 | $6.49 -1.22% 10.94% 6
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.